Assessment of a Helium/Argon-Generated Cold Atmospheric Plasma Device’s Safety Utilizing a Pig Model
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167854 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xin-Rui Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea. Hauptthemen laut MEDLINE: Argon, Plasma Gases, Helium, Skin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The PlazMagik device is a dual-gas cold atmospheric plasma (CAP) system that was developed and used for skin rejuvenation and inflammation treatment. However, preclinical evaluation and optimization of plasma parameters are crucial for guaranteeing safety. Therefore, this study was performed to evaluate the safety of the PlazMagik device under multiple parameters with different gas resources (helium (He) and argon (Ar) gases) on pig dorsal skin. After application of PlazMagik to the pig’s dorsal skin, temperature and visual assessments were observed immediately and for up to 30 days. All clinical parameters, including body weight and blood serum biochemistry, along with histopathological analysis (H&E, MT, VB, NBTC staining), were monitored pre-application and at 1, 7, 15, and 30 days post-application of the plasma device. Our results confirmed the safety of the machine at low-output energy settings, which showed gentle skin exfoliation but no tissue damage, while high-output settings led to the skin erosion effect, then developing erythema and coagulation. Ar gas resulted in more significant heat production and pathological changes than He under identical conditions. These findings emphasize the importance of the preclinical evaluation of the energy settings and gas selection on optimizing CAP system performance for safe clinical applications and appropriate application purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.
- Department of Plastic and Reconstructive Surgery, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
- Department of Plastic and Aesthetic Surgery, Peking Union Medical College Hospital, Beijing 100730, China.
- Korean Institute of Nonclinical Study Center, Seongnam 13620, Republic of Korea.
- Department of Biomedical Science, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
- Department of Medical Technology, Hai Phong University of Medicine and Pharmacy, Haiphong 180000, Vietnam.
ORCID-Profile: Xin-Rui Zhang, Thuy-Tien Thi Trinh, Yong-Xun Jin, Pham Ngoc Chien, Chan-Yeong Heo
Zitieren
APA
Zhang, X. R., Trinh, T. T., Thuy, L. L. T., Giang, N. N., Jin, Y. X., Lee, Y. H., Ahn, G. Y., Goo, B. L., Jung, K. S., Hwang, H. S., Chien, P. N., & Heo, C. Y. (2025). Assessment of a Helium/Argon-Generated Cold Atmospheric Plasma Device’s Safety Utilizing a Pig Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167854
Vancouver
Zhang XR, Trinh TT, Thuy LLT, Giang NN, Jin YX, Lee YH, et al. Assessment of a Helium/Argon-Generated Cold Atmospheric Plasma Device’s Safety Utilizing a Pig Model. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167854
BibTeX
@article{Zhang2025,
author = {Zhang, Xin-Rui and Trinh, Thuy-Tien Thi and Thuy, Linh Le Thi and Giang, Nguyen Ngan and Jin, Yong-Xun and Lee, Young-Hyun and Ahn, Gun-Young and Goo, Boncheol Leo and Jung, Kyoung-Su and Hwang, Hyun-Soo and Chien, Pham Ngoc and Heo, Chan-Yeong},
title = {Assessment of a Helium/Argon-Generated Cold Atmospheric Plasma Device’s Safety Utilizing a Pig Model},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167854}
}
EUVIMED